355 related articles for article (PubMed ID: 15681300)
1. B1 kinin receptor does not contribute to vascular tone or tissue plasminogen activator release in the peripheral circulation of patients with heart failure.
Cruden NL; Tse GH; Fox KA; Ludlam CA; Megson I; Newby DE
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):772-7. PubMed ID: 15681300
[TBL] [Abstract][Full Text] [Related]
2. Vascular B1 kinin receptors in patients with congestive heart failure.
Lang NN; Cruden NL; Tse GH; Bloomfield P; Ludlam CA; Fox KA; Newby DE
J Cardiovasc Pharmacol; 2008 Nov; 52(5):438-44. PubMed ID: 19033823
[TBL] [Abstract][Full Text] [Related]
3. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE
Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy.
Vianna RM; Calixto JB
Br J Pharmacol; 1998 Jan; 123(2):281-91. PubMed ID: 9489617
[TBL] [Abstract][Full Text] [Related]
5. Marked impairment of protease-activated receptor type 1-mediated vasodilation and fibrinolysis in cigarette smokers: smoking, thrombin, and vascular responses in vivo.
Lang NN; Gudmundsdóttir IJ; Boon NA; Ludlam CA; Fox KA; Newby DE
J Am Coll Cardiol; 2008 Jul; 52(1):33-9. PubMed ID: 18582632
[TBL] [Abstract][Full Text] [Related]
6. Neutral endopeptidase inhibition augments vascular actions of bradykinin in patients treated with angiotensin-converting enzyme inhibition.
Cruden NL; Fox KA; Ludlam CA; Johnston NR; Newby DE
Hypertension; 2004 Dec; 44(6):913-8. PubMed ID: 15492133
[TBL] [Abstract][Full Text] [Related]
7. Vasomotor and fibrinolytic responses to kinin receptor agonists in the atherosclerotic human lower limb.
Cruden NL; Lang NN; MacGillivray TJ; Uren NG; Fox KA; Newby DE
Heart Vessels; 2012 Mar; 27(2):179-85. PubMed ID: 21394642
[TBL] [Abstract][Full Text] [Related]
8. Coronary vasomotor response to the selective B1-kinin-receptor agonist Des-Arg9-bradykinin in humans.
Aptecar E; Lecorvoisier P; Teiger E; Garot P; Dupouy P; Sediame S; Vermes E; Loisance D; Hittinger L; Dubois-Rande JL; Montagne O
J Heart Lung Transplant; 2006 Feb; 25(2):187-94. PubMed ID: 16446219
[TBL] [Abstract][Full Text] [Related]
9. Bradykinin receptor antagonism and endothelial tissue plasminogen activator release in humans.
Witherow FN; Dawson P; Ludlam CA; Webb DJ; Fox KA; Newby DE
Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1667-70. PubMed ID: 12869356
[TBL] [Abstract][Full Text] [Related]
10. Vascular and fibrinolytic effects of intra-arterial tumour necrosis factor-alpha in patients with coronary heart disease.
Robinson SD; Dawson P; Ludlam CA; Boon NA; Newby DE
Clin Sci (Lond); 2006 Mar; 110(3):353-60. PubMed ID: 16309383
[TBL] [Abstract][Full Text] [Related]
11. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
[TBL] [Abstract][Full Text] [Related]
12. The role of B1 and B2 kinin receptors in oedema formation after long-term treatment with Mycobacterium bovis bacillus Calmette-Guérin (BCG).
Campos MM; Henriques MG; Calixto JB
Br J Pharmacol; 1997 Feb; 120(3):502-8. PubMed ID: 9031756
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme inhibition increases basal vascular tissue plasminogen activator release in women but not in men.
Pretorius M; Luther JM; Murphey LJ; Vaughan DE; Brown NJ
Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2435-40. PubMed ID: 16166566
[TBL] [Abstract][Full Text] [Related]
14. Marked bradykinin-induced tissue plasminogen activator release in patients with heart failure maintained on long-term angiotensin-converting enzyme inhibitor therapy.
Witherow FN; Dawson P; Ludlam CA; Fox KA; Newby DE
J Am Coll Cardiol; 2002 Sep; 40(5):961-6. PubMed ID: 12225723
[TBL] [Abstract][Full Text] [Related]
15. Intra-arterial tumor necrosis factor-alpha impairs endothelium-dependent vasodilatation and stimulates local tissue plasminogen activator release in humans.
Chia S; Qadan M; Newton R; Ludlam CA; Fox KA; Newby DE
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):695-701. PubMed ID: 12692009
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of bradykinin-induced tissue plasminogen activator release by angiotensin-converting enzyme inhibition.
Labinjoh C; Newby DE; Pellegrini MP; Johnston NR; Boon NA; Webb DJ
J Am Coll Cardiol; 2001 Nov; 38(5):1402-8. PubMed ID: 11691515
[TBL] [Abstract][Full Text] [Related]
17. The role of kinin B1 receptors in the nociception produced by peripheral protein kinase C activation in mice.
Ferreira J; Trichês KM; Medeiros R; Cabrini DA; Mori MA; Pesquero JB; Bader M; Calixto JB
Neuropharmacology; 2008 Mar; 54(3):597-604. PubMed ID: 18164734
[TBL] [Abstract][Full Text] [Related]
18. Different B1 kinin receptor expression and pharmacology in endothelial cells of different origins and species.
Wohlfart P; Dedio J; Wirth K; Schölkens BA; Wiemer G
J Pharmacol Exp Ther; 1997 Feb; 280(2):1109-16. PubMed ID: 9023330
[TBL] [Abstract][Full Text] [Related]
19. Effects of acute angiotensin II type 1 receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patients with heart failure.
Goodfield NE; Newby DE; Ludlam CA; Flapan AD
Circulation; 1999 Jun; 99(23):2983-5. PubMed ID: 10368114
[TBL] [Abstract][Full Text] [Related]
20. Bradykinin contributes to the vasodilator effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
Witherow FN; Helmy A; Webb DJ; Fox KA; Newby DE
Circulation; 2001 Oct; 104(18):2177-81. PubMed ID: 11684627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
